Personnel Information

写真a

KIRIMURA Susumu


Job title

Assistant Professor
To the head of this page.▲

Campus Career 【 display / non-display 】

  • 2015.04
    -
    2017.03
    Tokyo Medical and Dental University， (Old Organization)Medical Hospital， Central Clinical Facilities， Pathology， Assistant Professor
  • 2017.04
    -
    2018.03
    Tokyo Medical and Dental University， (Old Organization)Medical Hospital， Central Clinical Facilities， Pathology， Assistant Professor
  • 2018.04
    -
    2021.09
    Tokyo Medical and Dental University， (Old Organization)Medical Hospital， Central Clinical Facilities， Pathology， Assistant Professor
  • 2019.04
    -
    Now
    Tokyo Medical and Dental University， Graduate School of Medical and Dental Sciences， Medical and Dental Sciences， Advanced Therapeutic Sciences， Surgical Pathology， Assistant Professor
  • 2021.10
    -
    Now
    Tokyo Medical and Dental University， Tokyo Medical and Dental University， Division of Integrated Facilities， Pathology， Assistant Professor
To the head of this page.▲
 

Published Papers & Misc 【 display / non-display 】

  1. Kubota N, Okamoto T, Shimada S, Yamana T, Iijima Y, Sakakibara R, Shibata S, Honda T, Mitsumura T, Shirai T, Furusawa H, Tateishi T, Adachi T, Kirimura S, Miyazaki Y. A Case of Solitary Pure Ground-glass Opacity Suspected of Being the Initial Presentation of Nonfibrotic Hypersensitivity Pneumonitis. Internal medicine (Tokyo, Japan). 2024.02; ( PubMed, DOI )

  2. Fujiwara Shun, Kano Yoshihito, Maejima Yasuhiro, Fujioka Tomoyuki, Tamura Kazuhiro, Kirimura Susumu, Miyake Satoshi, Okamoto Ryuichi. Clinical Response of Primary Malignant Pericardial Mesothelioma with Peritoneal Dissemination to Nivolumab(タイトル和訳中) Internal Medicine. 2024.02; 63 (4): 513-519. ( ichushi )

  3. Iijima Y, Ejima M, Yamana T, Sonoda S, Shibata S, Shirai T, Okamoto T, Furusawa H, Tateishi T, Adachi T, Mori M, Kirimura S, Anzai T, Takahashi K, Miyazaki Y. Assessment of clinical relevance of antigen improves diagnostic accuracy of hypersensitivity pneumonitis. BMC pulmonary medicine. 2024.02; 24 (1): 84. ( PubMed, DOI )

  4. Nishikawa, T; Tomoda, T; Nakamura, A; Nagahama, J; Tanaka, A; Kanmura, S; Kirishima, M; Tanimoto, A; Okano, T; Kamiya, T; Okamoto, K; Kirimura, S; Morio, T; Okamoto, Y; Kanegane, H. Case Report: The leopard sign as a potential characteristic of chronic granulomatous disease-associated colitis, unrelated to colitis severity FRONTIERS IN IMMUNOLOGY. 2023.12; 14 1208590. ( PubMed, DOI )

  5. Yin Y, Sakakibara R, Honda T, Kirimura S, Daroonpan P, Kobayashi M, Ando K, Ujiie H, Kato T, Kaga K, Mitsumura T, Nakano R, Sakashita H, Matsuge S, Ishibashi H, Akashi T, Hida Y, Morohoshi T, Azuma M, Okubo K, Miyazaki Y. High density and proximity of CD8(+) T cells to tumor cells are correlated with better response to nivolumab treatment in metastatic pleural mesothelioma. Thoracic cancer. 2023.07; 14 (20): 1991-2000. ( PubMed, DOI )

  6. Fujiwara S, Kano Y, Maejima Y, Fujioka T, Tamura K, Kirimura S, Miyake S, Okamoto R. Clinical Response of Primary Malignant Pericardial Mesothelioma with Peritoneal Dissemination to Nivolumab. Internal medicine (Tokyo, Japan). 2023.06; 63 (4): 513-519. ( PubMed, DOI )

  7. Miyauchi M, Akashi T, Furukawa A, Uchida K, Tamura T, Ando N, Kirimura S, Shintaku H, Yamamoto K, Ito T, Miura K, Kayamori K, Ariizumi Y, Asakage T, Kudo A, Tanabe M, Fujii Y, Ishibashi H, Okubo K, Murakami M, Yamada T, Takemoto A, Bae Y, Eishi Y, Ohashi K. PHOX2B is a Sensitive and Specific Marker for the Histopathological Diagnosis of Pheochromocytoma and Paraganglioma. Endocr Pathol. 2022.12; 33 (4): 506-518.

  8. Miyauchi, M; Akashi, T; Furukawa, A; Uchida, K; Tamura, T; Ando, N; Kirimura, S; Shintaku, H; Yamamoto, K; Ito, T; Miura, K; Kayamori, K; Ariizumi, Y; Asakage, T; Kudo, A; Tanabe, M; Fujii, Y; Ishibashi, H; Okubo, K; Murakami, M; Yamada, T; Takemoto, A; Bae, Y; Eishi, Y; Ohashi, K. PHOX2B is a Sensitive and Specific Marker for the Histopathological Diagnosis of Pheochromocytoma and Paraganglioma ENDOCRINE PATHOLOGY. 2022.12; 33 (4): 506-518. ( PubMed, DOI )

  9. Onishi Iichiroh, Kirimura Susumu, Wakejima Ryo, Okubo Kenichi, Odai Tamami, Kakuta Ryota, Kano Yoshihito, Ikeda Sadakatsu, Akashi Takumi, Kitagawa Masanobu. Primary pulmonary choriocarcinoma with a genomic sequence(和訳中) Pathology International. 2022.02; 72 (2): 141-143.

  10. Okazaki T, Yokoyama K, Tsuchiya J, Honda T, Ishikawa Y, Kirimura S, Miyazaki Y, Tateishi U. SMARCA4-deficient thoracic tumor detected by [<sup>18</sup>F]FDG PET/CT. European journal of hybrid imaging. 2021.04; 5 (1): 8. ( PubMed, DOI )

  11. Suga T, Takenoshita M, Tu TTH, Sugawara T, Kirimura S, Toyofuku A. A case of vestibular schwannoma mimicking burning mouth syndrome. BioPsychoSocial medicine. 2021.03; 15 (1): 7. ( PubMed, DOI )

  12. Suga Takayuki, Takenoshita Miho, Trang T.H. Tu, Sugawara Takashi, Kirimura Susumu, Toyofuku Akira. 口腔灼熱症候群に類似した前庭神経鞘腫の一症例(A case of vestibular schwannoma mimicking burning mouth syndrome) Biopsychosocial Medicine. 2021.03; 15 1 of 4-4 of 4. ( ichushi )

  13. Watanabe S, Nishimura R, Shirasaki T, Katsukura N, Hibiya S, Kirimura S, Negi M, Okamoto R, Matsumoto Y, Nakamura T, Watanabe M, Tsuchiya K. Schlafen 11 is a novel target for mucosal regeneration in Ulcerative Colitis. Journal of Crohn's & colitis. 2021.02; 15 (9): 1558-1572. ( PubMed, DOI )

  14. Tsugeno Yuta, Kawachi Hiroshi, Kirimura Susumu, Hirota Yuka, Shintaku Hiroshi, Ito Takashi, Kikuchi Akifumi, Ohtsuka Kazuo, Akashi Takumi, Kitagawa Masanobu. Adenocarcinoma arising in the multiple heterotopic submucosal glands of the intestine in a Satoyoshi syndrome patient: A case report PATHOLOGY INTERNATIONAL. 2021.02; 71 (2): 147-154. ( PubMed, DOI )

  15. Katsukura Nobuhiro, Watanabe Sho, Shirasaki Tomoaki, Hibiya Shuji, Kano Yoshihito, Akahoshi Keiichi, Tanabe Minoru, Kirimura Susumu, Akashi Takumi, Kitagawa Masanobu, Okamoto Ryuichi, Watanabe Mamoru, Tsuchiya Kiichiro. 膵管内乳頭粘液性腫瘍の癌領域において腸の表現型がAtoh1によって維持されている(Intestinal phenotype is maintained by Atoh1 in the cancer region of intraductal papillary mutinous neoplasm) Cancer Science. 2021.02; 112 (2): 932-944. ( ichushi )

  16. Tsugeno Yuta, Kawachi Hiroshi, Kirimura Susumu, Hirota Yuka, Shintaku Hiroshi, Ito Takashi, Kikuchi Akifumi, Ohtsuka Kazuo, Akashi Takumi, Kitagawa Masanobu. 里吉症候群患者の多発性異所性腸粘膜下腺から発生した腺癌(Adenocarcinoma arising in the multiple heterotopic submucosal glands of the intestine in a Satoyoshi syndrome patient: A case report) Pathology International. 2021.02; 71 (2): 147-154. ( ichushi )

  17. Soma T, Yokoyama M, Uchida Y, Kirimura S, Tanaka H, Yoshida S, Matsuoka Y, Fujii Y. Long-term survival after radical cystectomy and mesenteric lymph node dissection for squamous cell carcinoma arising from augmented bladder with lymph node metastasis: a case report. International cancer conference journal. 2021.01; 10 (1): 20-23. ( PubMed, DOI )

  18. Soma Takahiko, Yokoyama Minato, Uchida Yusuke, Kirimura Susumu, Tanaka Hajime, Yoshida Soichiro, Matsuoka Yoh, Fujii Yasuhisa. 膀胱増大に起因する扁平上皮癌とリンパ節転移に対して根治的膀胱切除術と腸間膜リンパ節郭清を行い長期生存した症例　1症例報告(Long-term survival after radical cystectomy and mesenteric lymph node dissection for squamous cell carcinoma arising from augmented bladder with lymph node metastasis: a case report) International Cancer Conference Journal. 2021.01; 10 (1): 20-23. ( ichushi )

  19. Katsukura Nobuhiro, Watanabe Sho, Shirasaki Tomoaki, Hibiya Shuji, Kano Yoshihito, Akahoshi Keiichi, Tanabe Minoru, Kirimura Susumu, Akashi Takumi, Kitagawa Masanobu, Okamoto Ryuichi, Watanabe Mamoru, Tsuchiya Kiichiro. Intestinal phenotype is maintained by Atoh1 in the cancer region of intraductal papillary mucinous neoplasm CANCER SCIENCE. 2020.12; 112 (2): 932-944. ( PubMed, DOI )

  20. Nakashima Yasuhiro, Inamura Kentaro, Ninomiya Hironori, Okumura Sakae, Mun Mingyon, Kirimura Susumu, Kobayashi Masashi, Okubo Kenichi, Ishikawa Yuichi. Frequent expression of conventional endothelial markers in pleural mesothelioma: usefulness of claudin-5 as well as combined traditional markers to distinguish mesothelioma from angiosarcoma LUNG CANCER. 2020.10; 148 20-27. ( PubMed, DOI )

  21. Miura K, Akashi T, Namiki T, Hishima T, Bae Y, Sakurai U, Murano K, Shiraishi J, Warabi M, Tanizawa T, Tanaka M, Bhunchet E, Kumagai J, Ayabe S, Sekiya T, Ando N, Shintaku H, Kinowaki Y, Tomii S, Kirimura S, Kayamori K, Yamamoto K, Ito T, Eishi Y. Engrailed Homeobox 1 and Cytokeratin 19 Are Independent Diagnostic Markers of Eccrine Porocarcinoma and Distinguish It From Squamous Cell Carcinoma. American journal of clinical pathology. 2020.06; 154 (4): 499-509. ( PubMed, DOI )

  22. Nakashima Y., Inamura K., Ninomiya H., Kirimura S., Kobayashi M., Okubo K., Ishikawa Y.. Overlapping Immunophenotypes Between Mesothelioma and Angiosarcoma: Usefulness of Claudin-5 in the Differential Diagnosis JOURNAL OF THORACIC ONCOLOGY. 2019.10; 14 (10): S482.

  23. Kobayashi Masashi, Ishibashi Hironori, Takasaki Chihiro, Imai Sachiko, Kirimura Susumu, Okubo Kenichi. Pathological evaluation of the visceral pleura in the radical pleurectomy/decortication for malignant pleural mesothelioma patients JOURNAL OF THORACIC DISEASE. 2019.03; 11 (3): 717-723. ( PubMed, DOI )

  24. Okada R, Ito T, Nomura F, Kirimura S, Cho Y, Sekine M, Tateishi Y, Ariizumi Y, Asakage T. The quantitative analysis of the human papillomavirus DNA load in submandibular gland lesions with droplet digital polymerase chain reaction. Acta oto-laryngologica. 2019.02; 139 (1): 1-6. ( PubMed, DOI )

  25. Masashi Kobayashi, Hironori Ishibashi, Chihiro Takasaki, Sachiko Imai, Susumu Kirimura, Kenichi Okubo. Pathological evaluation of the visceral pleura in the radical P/D for MPM patients Journal of Thoracic Disease. 2019.01;

  26. Takuya Adachi, Minato Yokoyama, Yasuhisa Fujii, Yuko Kinowaki, Susumu Kirimura, Kazunori Kubota, Yukihisa Saida, Ukihide Tateishi. Neuroblastic tumors in young adults as a sequela of malignant neuroblastoma: report of two cases. Abdom Radiol (NY). 2018.07; 43 (7): 1531-1534. ( PubMed, DOI )

  27. Hiroki Yamada, Takahiro Takeda, Toshiki Uchihara, Shizuko Sato, Susumu Kirimura, Yuka Hirota, Makoto Kodama, Masanobu Kitagawa, Katsuiku Hirokawa, Takanori Yokota, Shuta Toru. Macroscopic Localized Subicular Thinning as a Potential Indicator of Amyotrophic Lateral Sclerosis. Eur. Neurol.. 2018; 79 (3-4): 200-205. ( PubMed, DOI )

  28. Oba Atsushi, Ban Daisuke, Kudo Atsushi, Kirimura Susumu, Ito Hiromitsu, Matsumura Satoshi, Mitsunori Yusuke, Aihara Arihiro, Ochiai Takanori, Tanaka Shinji, Tanabe Minoru. Correlation Between the Acquisition of Resistance to Gemcitabine Therapy and the Expression of HuR in Pancreatic Ductal Adenocarcinoma: A Case Report INTERNATIONAL SURGERY. 2018; 103 (1-2): 116-120. ( DOI )

  29. Miyamoto Norikazu, Kurata Morito, Nagiri Toshiya, Abe Shinya, Yamamoto Kouhei, Onishi Iichiroh, Kirimura Susumu, Murayama Toshihiko, Hidaka Michihiro, Kitagawa Masanobu. Differential expression of ACINUS variants in bone marrow in myelodysplastic syndromes INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY. 2017; 10 (4): 4330-4338.

  30. Oba A, Ban D, Kirimura S, Akahoshi K, Mitsunori Y, Matsumura S, Ochiai T, Kudo A, Tanaka S, Minoru T.. Clinical application of the biomarkers for the selection of adjuvant chemotherapy in pancreatic ductal adenocarcinoma. J Hepatobiliary Pancreat Sci. . 2016.08; 23 (8): 480-488.

  31. Oba Atsushi, Ban Daisuke, Kirimura Susumu, Akahoshi Keiichi, Mitsunori Yusuke, Matsumura Satoshi, Ochiai Takanori, Kudo Atsushi, Tanaka Shinji, Tanabe Minoru. 膵管腺癌の術後補助化学療法を選択するバイオマーカーの臨床適用(Clinical application of the biomarkers for the selection of adjuvant chemotherapy in pancreatic ductal adenocarcinoma) Journal of Hepato-Biliary-Pancreatic Sciences. 2016.08; 23 (8): 480-488. ( ichushi )

  32. Oba, A; Ban, D; Kirimura, S; Akahoshi, K; Mitsunori, Y; Matsumura, S; Ochiai, T; Kudo, A; Tanaka, S; Minoru, T. Clinical application of the biomarkers for the selection of adjuvant chemotherapy in pancreatic ductal adenocarcinoma JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES. 2016.08; 23 (8): 480-488. ( PubMed, DOI )

  33. Susumu Kirimura, Morito Kurata, Yasunori Nakagawa, Iichiroh Onishi, Shiho Abe-Suzuki, Shinya Abe, Kouhei Yamamoto, Masanobu Kitagawa. Role of microRNA-29b in myelodysplastic syndromes during transformation to overt leukaemia. Pathology. 2016.04; 48 (3): 233-241. ( PubMed, DOI )

  34. Tsunoda Atsunobu, Tanaka Yoji, Sato Takanobu, Kirimura Susumu, Kitamura Ken. 治療から33年後にめまいが出現した乳癌転移症例(Vertigo by Breast Cancer Metastasis 33 Years after Treatment) Internal Medicine. 2016.02; 55 (3): 311-313. ( ichushi )

  35. Yamamoto K, Miwa Y, Abe-Suzuki S, Abe S, Kirimura S, Onishi I, Kitagawa M, Kurata M. Extramedullary hematopoiesis: Elucidating the function of the hematopoietic stem cell niche (Review). Molecular medicine reports. 2016.01; 13 (1): 587-591.

  36. Yamamoto Kouhei, Miwa Yukako, Abe-Suzuki Shiho, Abe Shinya, Kirimura Susumu, Onishi Iichiroh, Kitagawa Masanobu, Kurata Morito. Extramedullary hematopoiesis: Elucidating the function of the hematopoietic stem cell niche MOLECULAR MEDICINE REPORTS. 2016.01; 13 (1): 587-591. ( PubMed, DOI )

  37. Atsunobu Tsunoda, Yoji Tanaka, Takanobu Sato, Susumu Kirimura, Ken Kitamura. Vertigo by Breast Cancer Metastasis 33 Years after Treatment. Intern. Med.. 2016; 55 (3): 311-313. ( PubMed, DOI )

  38. 木脇 祐子, 山本 浩平, 阿部 晋也, 阿部 志保, 大西 威一郎, 桐村 進, 木原 淳. びまん性大細胞リンパ腫におけるGPX4の臨床病理学的検討 日本癌学会総会記事. 2015.10; 74回 P-3231. ( ichushi )

  39. Abe-Suzuki S, Kurata M, Abe S, Onishi I, Kirimura S, Nashimoto M, Murayama T, Hidaka M, Kitagawa M.. CXCL12+ stromal cells as bone marrow niche for CD34+ hematopoietic cells and their association with disease progression in myelodysplastic syndromes. Laboratory investigation. 2014.11; 94 (11): 1212-1223.

  40. Abe-Suzuki Shiho, Kurata Morito, Abe Shinya, Onishi Iichiroh, Kirimura Susumu, Nashimoto Manami, Murayama Toshihiko, Hidaka Michihiro, Kitagawa Masanobu. CXCL12(+) stromal cells as bone marrow niche for CD34(+) hematopoietic cells and their association with disease progression in myelodysplastic syndromes LABORATORY INVESTIGATION. 2014.11; 94 (11): 1212-1223. ( PubMed, DOI )

  41. Kano Y, Kakinuma S, Goto F, Azuma S, Nishimura-Sakurai Y, Itsui Y, Nakagawa M, Kudo A, Tanabe M, Kirimura S, Amano T, Ito T, Akashi T, Asahina Y, Watanabe M.. Primary hepatic neuroendocrine carcinoma with a cholangiocellular carcinoma component in one nodule. Journal of gastroenterology. 2014.10; 7 (5): 449-454.

  42. Kano Y, Kakinuma S, Goto F, Azuma S, Nishimura-Sakurai Y, Itsui Y, Nakagawa M, Kudo A, Tanabe M, Kirimura S, Amano T, Ito T, Akashi T, Asahina Y, Watanabe M. Primary hepatic neuroendocrine carcinoma with a cholangiocellular carcinoma component in one nodule. Clinical journal of gastroenterology. 2014.10; 7 (5): 449-54. ( PubMed, DOI )

  43. Kano Yoshihito, Kakinuma Sei, Goto Fumio, Azuma Seishin, Nishimura-Sakurai Yuki, Itsui Yasuhiro, Nakagawa Mina, Kudo Atsushi, Tanabe Minoru, Kirimura Susumu, Amano Tomonori, Ito Takashi, Akashi Takumi, Asahina Yasuhiro, Watanabe Mamoru. 結節の一つに胆管細胞癌部分を合併した原発性肝神経内分泌癌(Primary hepatic neuroendocrine carcinoma with a cholangiocellular carcinoma component in one nodule) Clinical Journal of Gastroenterology. 2014.10; 7 (5): 449-454. ( ichushi )

  44. Li Na, Abe Shinya, Kurata Morito, Abe-Suzuki Shiho, Onishi Iichiroh, Kirimura Susumu, Murayama Toshihiko, Hidaka Michihiro, Kawano Fumio, Kitagawa Masanobu. Over-Expression of Cancerous Inhibitor of PP2A (CIP2A) in Bone Marrow Cells from Patients with a Group of High-Risk Myelodysplastic Syndromes PATHOLOGY & ONCOLOGY RESEARCH. 2014.04; 20 (2): 399-407. ( PubMed, DOI )

  45. Na Li, Shinya Abe, Morito Kurata, Shiho Abe, Iichiroh Onishi, Susumu Kirimura, Toshihiko Murayama, Michihiro Hidaka, Fumio Kawano, Masanobu Kitagawa.. Over-Expression of Cancerous Inhibitor of PP2A (CIP2A) in Bone Marrow Cells from Patients with Group of High Risk Myelodysplastic Syndromes. pathology and oncology research. 2013.10; 20 399-407.

  46. Miwa Y, Hayashi T, Suzuki-Abe S, Abe S, Onishi I, Kirimura S, Kitagawa M, Kurata M. . Up-regulated expression of CXCL12 in human spleens with extramedullary hematopoiesis. Pathology. 2013.06; 45 (4): 408-416.

  47. Miwa Yukako, Hayashi Tomohito, Suzuki Shiho, Abe Shinya, Onishi Iichiroh, Kirimura Susumu, Kitagawa Masanobu, Kurata Morito. Up-regulated expression of CXCL12 in human spleens with extramedullary haematopoiesis PATHOLOGY. 2013.06; 45 (4): 408-416. ( PubMed, DOI )

  48. Yagi K, Yamamoto K, Umeda S, Abe S, Suzuki-Abe S, Onishi I, Kirimura S, Fukayama M, Arai A, Murayama T, Hidaka M, Kitagawa M, Kurata M. Expression of multidrug resistance 1 gene in B-cell lymphomas: association with follicular dendritic cells. Histopathology. 2013.02; 62 (3): 414-420.

  49. Yagi Keiko, Yamamoto Kouhei, Umeda Shigeaki, Abe Shinya, Suzuki Shiho, Onishi Iichiroh, Kirimura Susumu, Fukayama Masashi, Arai Ayako, Kitagawa Masanobu, Kurata Morito. Expression of multidrug resistance 1 gene in B-cell lymphomas: association with follicular dendritic cells HISTOPATHOLOGY. 2013.02; 62 (3): 414-420. ( PubMed, DOI )

  50. Kuninaka N, Kurata M, Yamamoto K, Suzuki S, Umeda S, Kirimura S, Arai A, Nakagawa Y, Suzuki K, Kitagawa M.. Expression of Toll-like receptor 9 in bone marrow cells of myelodysplastic syndromes is down-regulated during transformation to overt leukemia. Experimental and molecular pathology. 2010.04; 88 293-298.

  51. Kuninaka Nobuo, Kurata Morito, Yamamoto Kouhei, Suzuki Shiho, Umeda Shigeaki, Kirimura Susumu, Arai Ayako, Nakagawa Yasunori, Suzuki Kenshi, Kitagawa Masanobu. Expression of Toll-like receptor 9 in bone marrow cells of myelodysplastic syndromes is down-regulated during transformation to overt leukemia EXPERIMENTAL AND MOLECULAR PATHOLOGY. 2010.04; 88 (2): 293-298. ( PubMed, DOI )

▼display all

To the head of this page.▲

Conference Activities & Talks 【 display / non-display 】

  1. Yin Yuting, Sakakibara Rie, Honda Takayuki, Mitsumura Takahiro, Kirimura Susumu, Okubo Kenichi, Azuma Miyuki, Miyazaki Yasunari. Potential Utility of Elucidation of Tumor Immune Microenvironment in Malignant Pleural Mesothelioma as Prognostic marker of Nivolumab(タイトル和訳中). 肺癌 2022.11.01

  2. Yin Yuting, Sakakibara Rie, Honda Takayuki, Mitsumura Takahiro, Kirimura Susumu, Okubo Kenichi, Azuma Miyuki, Miyazaki Yasunari. 悪性胸膜中皮腫の腫瘍免疫微小環境の解明(Elucidation of Tumor Immune Microenvironment in Malignant Pleural Mesothelioma). 日本呼吸器学会誌 2022.04.01

  3. Yuting Yin, Sakakibara Rie, Honda Takayuki, Mitsumura Takahiro, Kirimura Susumu, Okubo Kenichi, Azuma Miyuki, Miyazaki Yasunari. 悪性胸膜中皮腫の腫瘍免疫微小環境(Tumor immune-microenvironment of Malignant Pleural Mesothelioma). 肺癌 2021.10.01

  4. 木脇 祐子, 山本 浩平, 石橋 佐知子, 阿部 志保, 大西 威一郎, 桐村 進, 木原 淳, 北川 昌伸. びまん性大細胞リンパ腫におけるGPX4の臨床病理学的検討. 日本癌学会総会記事 2016.10.01

  5. 木脇 祐子, 山本 浩平, 石橋 佐知子, 阿部 志保, 大西 威一郎, 桐村 進, 木原 淳, 北川 昌伸. びまん性大細胞リンパ腫におけるGPX4の臨床病理学的検討. 日本癌学会総会記事 2016.10.01

  6. 木脇 祐子, 山本 浩平, 石橋 佐知子, 阿部 志保, 大西 威一郎, 桐村 進, 木原 淳, 北川 昌伸. びまん性大細胞リンパ腫におけるGPX4の臨床病理学的検討. 日本癌学会総会記事 2016.10.01

  7. Oba Atsushi, Ban Daisuke, Kirimura Susumu, Akahoshi Keiichi, Kudo Atsushi, Ito Hiromitsu, Matsumura Satoshi, Mitsunori Yusuke, Aihara Arihiro, Ochiai Takanori, Tanaka Shinji, Tanabe Minoru. 膵管腺癌におけるゲムシタビン+S-1併用アジュバント化学療法の選択へのバイオマーカーの影響(Impact of the Biomarkers for the Selection of Gemcitabine and S-1 Adjuvant Chemotherapy in Pancreatic Ductal Adenocarcinoma). 膵臓 2016.07.01

  8. Oba Atsushi, Ban Daisuke, Kirimura Susumu, Akahoshi Keiichi, Kudo Atsushi, Ito Hiromitsu, Matsumura Satoshi, Mitsunori Yusuke, Aihara Arihiro, Ochiai Takanori, Tanaka Shinji, Tanabe Minoru. 膵管腺癌におけるゲムシタビン+S-1併用アジュバント化学療法の選択へのバイオマーカーの影響(Impact of the Biomarkers for the Selection of Gemcitabine and S-1 Adjuvant Chemotherapy in Pancreatic Ductal Adenocarcinoma). 膵臓 2016.07.01

  9. Oba Atsushi, Ban Daisuke, Kirimura Susumu, Akahoshi Keiichi, Kudo Atsushi, Ito Hiromitsu, Matsumura Satoshi, Mitsunori Yusuke, Aihara Arihiro, Ochiai Takanori, Tanaka Shinji, Tanabe Minoru. 膵管腺癌におけるゲムシタビン+S-1併用アジュバント化学療法の選択へのバイオマーカーの影響(Impact of the Biomarkers for the Selection of Gemcitabine and S-1 Adjuvant Chemotherapy in Pancreatic Ductal Adenocarcinoma). 膵臓 2016.07.01

  10. 北川 昌伸, 阿部 志保, 倉田 盛人, 阿部 晋也, 大西 威一郎, 桐村 進, 山本 浩平. 骨髄異形成症候群の骨髄におけるCXCL12陽性細胞. 日本癌学会総会記事 2015.10.01

  11. 木脇 祐子, 山本 浩平, 阿部 晋也, 阿部 志保, 大西 威一郎, 桐村 進, 木原 淳. びまん性大細胞リンパ腫におけるGPX4の臨床病理学的検討. 日本癌学会総会記事 2015.10.01

  12. 北川 昌伸, 阿部 志保, 倉田 盛人, 阿部 晋也, 大西 威一郎, 桐村 進, 山本 浩平. 骨髄異形成症候群の骨髄におけるCXCL12陽性細胞. 日本癌学会総会記事 2015.10.01

  13. 木脇 祐子, 山本 浩平, 阿部 晋也, 阿部 志保, 大西 威一郎, 桐村 進, 木原 淳. びまん性大細胞リンパ腫におけるGPX4の臨床病理学的検討. 日本癌学会総会記事 2015.10.01

  14. 北川 昌伸, 阿部 志保, 倉田 盛人, 阿部 晋也, 大西 威一郎, 桐村 進, 山本 浩平. 骨髄異形成症候群の骨髄におけるCXCL12陽性細胞. 日本癌学会総会記事 2015.10.01

  15. 桐村 進, 倉田 盛人, 中川 靖章, 大西 威一郎, 阿部 志保, 阿部 晋也, 山本 浩平, 北川 昌伸. 骨髄異形成症候群の白血病化におけるmicroRNA 29bの役割の検討(Role of microRNA 29b in myelodysplastic syndromes during the course of transformation to overt leukemia). 日本癌学会総会記事 2014.09.01

  16. 阿部 志保, 山本 浩平, 阿部 晋也, 桐村 進, 村山 寿彦, 北川 昌伸. 骨髄異形成症候群におけるCXCL12発現解析(Expression analysis of CXCL12 in myelodysplastic syndromes). 日本癌学会総会記事 2014.09.01

  17. 北川 昌伸, 阿部 晋也, 阿部 志保, 倉田 盛人, 山本 浩平, 大西 威一郎, 桐村 進, 木原 淳, 遠藤 祐子. MCM2によるアポトーシス増強機構(Apoptotic enhancement by MCM2). 日本癌学会総会記事 2014.09.01

  18. 阿部 晋也, 山本 浩平, 阿部 志保, 桐村 進, 北川 昌伸. DNA損傷誘発アポトーシス増強による新規癌治療モデルの開発(A novel model of cancer therapy by enhancing DNA-damage-induced apoptosis). 日本癌学会総会記事 2014.09.01

  19. 阿部 晋也, 山本 浩平, 阿部 志保, 桐村 進, 北川 昌伸. DNA損傷誘発アポトーシス増強による新規癌治療モデルの開発(A novel model of cancer therapy by enhancing DNA-damage-induced apoptosis). 日本癌学会総会記事 2014.09.01

  20. 桐村 進, 倉田 盛人, 中川 靖章, 大西 威一郎, 阿部 志保, 阿部 晋也, 山本 浩平, 北川 昌伸. 骨髄異形成症候群の白血病化におけるmicroRNA 29bの役割の検討(Role of microRNA 29b in myelodysplastic syndromes during the course of transformation to overt leukemia). 日本癌学会総会記事 2014.09.01

  21. 阿部 志保, 山本 浩平, 阿部 晋也, 桐村 進, 村山 寿彦, 北川 昌伸. 骨髄異形成症候群におけるCXCL12発現解析(Expression analysis of CXCL12 in myelodysplastic syndromes). 日本癌学会総会記事 2014.09.01

  22. 北川 昌伸, 阿部 晋也, 阿部 志保, 倉田 盛人, 山本 浩平, 大西 威一郎, 桐村 進, 木原 淳, 遠藤 祐子. MCM2によるアポトーシス増強機構(Apoptotic enhancement by MCM2). 日本癌学会総会記事 2014.09.01

  23. 阿部 晋也, 山本 浩平, 阿部 志保, 桐村 進, 北川 昌伸. DNA損傷誘発アポトーシス増強による新規癌治療モデルの開発(A novel model of cancer therapy by enhancing DNA-damage-induced apoptosis). 日本癌学会総会記事 2014.09.01

  24. 桐村 進, 倉田 盛人, 中川 靖章, 大西 威一郎, 阿部 志保, 阿部 晋也, 山本 浩平, 北川 昌伸. 骨髄異形成症候群の白血病化におけるmicroRNA 29bの役割の検討(Role of microRNA 29b in myelodysplastic syndromes during the course of transformation to overt leukemia). 日本癌学会総会記事 2014.09.01

  25. 阿部 志保, 山本 浩平, 阿部 晋也, 桐村 進, 村山 寿彦, 北川 昌伸. 骨髄異形成症候群におけるCXCL12発現解析(Expression analysis of CXCL12 in myelodysplastic syndromes). 日本癌学会総会記事 2014.09.01

  26. 北川 昌伸, 阿部 晋也, 阿部 志保, 倉田 盛人, 山本 浩平, 大西 威一郎, 桐村 進, 木原 淳, 遠藤 祐子. MCM2によるアポトーシス増強機構(Apoptotic enhancement by MCM2). 日本癌学会総会記事 2014.09.01

  27. 阿部 志保, 阿部 晋也, 倉田 盛人, 大西 威一郎, 桐村 進, 村山 寿彦, 北川 昌伸. 骨髄異形成症候群骨髄におけるCXCL12発現解析(Expression analysis of CXCL12 in myelodysplastic syndromes). 日本癌学会総会記事 2013.10.01

  28. 桐村 進, 倉田 盛人, 中川 靖章, 大西 威一郎, 阿部 志保, 阿部 晋也, 北川 昌伸. 骨髄異形成症候群の白血化におけるmicroRNA 29b(mir-29b)の役割の検討(Role of micro RNA 29b(mir-29b) in myelodysplastic syndromes during the course of transformation to overt leukemia). 日本癌学会総会記事 2013.10.01

  29. 北川 昌伸, 阿部 晋也, 倉田 盛人, 阿部 志保, 大西 威一郎, 桐村 進. DNA損傷アポトーシス増強によるがん治療モデル(In vivo model of cancer therapy by enhancing DNA-damageinduced apoptosis). 日本癌学会総会記事 2013.10.01

  30. 北川 昌伸, 阿部 晋也, 倉田 盛人, 阿部 志保, 大西 威一郎, 桐村 進. DNA損傷アポトーシス増強によるがん治療モデル(In vivo model of cancer therapy by enhancing DNA-damageinduced apoptosis). 日本癌学会総会記事 2013.10.01

  31. 阿部 志保, 阿部 晋也, 倉田 盛人, 大西 威一郎, 桐村 進, 村山 寿彦, 北川 昌伸. 骨髄異形成症候群骨髄におけるCXCL12発現解析(Expression analysis of CXCL12 in myelodysplastic syndromes). 日本癌学会総会記事 2013.10.01

  32. 桐村 進, 倉田 盛人, 中川 靖章, 大西 威一郎, 阿部 志保, 阿部 晋也, 北川 昌伸. 骨髄異形成症候群の白血化におけるmicroRNA 29b(mir-29b)の役割の検討(Role of micro RNA 29b(mir-29b) in myelodysplastic syndromes during the course of transformation to overt leukemia). 日本癌学会総会記事 2013.10.01

  33. 北川 昌伸, 阿部 晋也, 倉田 盛人, 阿部 志保, 大西 威一郎, 桐村 進. DNA損傷アポトーシス増強によるがん治療モデル(In vivo model of cancer therapy by enhancing DNA-damageinduced apoptosis). 日本癌学会総会記事 2013.10.01

  34. 阿部 志保, 阿部 晋也, 倉田 盛人, 大西 威一郎, 桐村 進, 村山 寿彦, 北川 昌伸. 骨髄異形成症候群骨髄におけるCXCL12発現解析(Expression analysis of CXCL12 in myelodysplastic syndromes). 日本癌学会総会記事 2013.10.01

  35. 桐村 進, 倉田 盛人, 中川 靖章, 大西 威一郎, 阿部 志保, 阿部 晋也, 北川 昌伸. 骨髄異形成症候群の白血化におけるmicroRNA 29b(mir-29b)の役割の検討(Role of micro RNA 29b(mir-29b) in myelodysplastic syndromes during the course of transformation to overt leukemia). 日本癌学会総会記事 2013.10.01

  36. 北川 昌伸, 阿部 晋也, 倉田 盛人, 鈴木 志保, 菅原 江美子, 大西 威一郎, 桐村 進. DNA損傷アポトーシス増強によるin vivo腫瘍治療モデル(In vivo model of tumor therapy by enhancing DNA-damage-induced apoptosis). 日本癌学会総会記事 2012.08.01

  37. 北川 昌伸, 阿部 晋也, 倉田 盛人, 鈴木 志保, 菅原 江美子, 大西 威一郎, 桐村 進. DNA損傷アポトーシス増強によるin vivo腫瘍治療モデル(In vivo model of tumor therapy by enhancing DNA-damage-induced apoptosis). 日本癌学会総会記事 2012.08.01

  38. 北川 昌伸, 阿部 晋也, 倉田 盛人, 鈴木 志保, 菅原 江美子, 大西 威一郎, 桐村 進. DNA損傷アポトーシス増強によるin vivo腫瘍治療モデル(In vivo model of tumor therapy by enhancing DNA-damage-induced apoptosis). 日本癌学会総会記事 2012.08.01

▼display all

To the head of this page.▲